Skip to main content Skip to navigation
Hamburger Menu
Search icon
Location Selector Location Selector
Middle East / Africa (English)
Products

Link Arrow
Solutions

Link Arrow
Discover & Learn

Link Arrow
Resources & Tools

Link Arrow
Support

Link Arrow
Close Menu

Dear Customer,  If you experience any text readability or display issues on our website, please update your web browser to the latest version

See More

Close
Website Feedback
Alert Icon
TRA181.png

Flow cytometric analysis of TRA-1-81 on human embryonic stem cells. H9 stem cells were stained with either Alexa Fluor® 647 mouse IgM, k Isotype Control (Cat. No. 560806; dashed line histogram), or Alexa Fluor® 647 Mouse anti-Human TRA-1-81 (Cat. No 560793; solid line histogram). Fluorescence histograms were derived from gated events based on the forward and side light scattering characteristics for viable H9 cells. Flow cytometry was performed on a BD LSRII™.

TRA181.png

Flow cytometric analysis of TRA-1-81 on human embryonic stem cells. H9 stem cells were stained with either Alexa Fluor® 647 mouse IgM, k Isotype Control (Cat. No. 560806; dashed line histogram), or Alexa Fluor® 647 Mouse anti-Human TRA-1-81 (Cat. No 560793; solid line histogram). Fluorescence histograms were derived from gated events based on the forward and side light scattering characteristics for viable H9 cells. Flow cytometry was performed on a BD LSRII™.

TRA181.png TRA181.png Red-Cap-Red-Label.jpg

Flow cytometric analysis of TRA-1-81 on human embryonic stem cells. H9 stem cells were stained with either Alexa Fluor® 647 mouse IgM, k Isotype Control (Cat. No. 560806; dashed line histogram), or Alexa Fluor® 647 Mouse anti-Human TRA-1-81 (Cat. No 560793; solid line histogram). Fluorescence histograms were derived from gated events based on the forward and side light scattering characteristics for viable H9 cells. Flow cytometry was performed on a BD LSRII™.

Flow cytometric analysis of TRA-1-81 on human embryonic stem cells. H9 stem cells were stained with either Alexa Fluor® 647 mouse IgM, k Isotype Control (Cat. No. 560806; dashed line histogram), or Alexa Fluor® 647 Mouse anti-Human TRA-1-81 (Cat. No 560793; solid line histogram). Fluorescence histograms were derived from gated events based on the forward and side light scattering characteristics for viable H9 cells. Flow cytometry was performed on a BD LSRII™.

Product Details
Down Arrow Up Arrow


BD Pharmingen™
Human (QC Testing)
Mouse BALB/c IgM, κ
Human Embryonal Carcinoma Cell Line
Flow cytometry (Routinely Tested)
20 µl
AB_10550550
Aqueous buffered solution containing BSA, protein stabilizer, and ≤0.09% sodium azide.
RUO


Preparation And Storage

Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated to Alexa Fluor® 647 under optimum conditions, and unreacted Alexa Fluor® 647 was removed.
Show More blue down arrow Show Less blue up arrow

Product Notices

  1. This reagent has been pre-diluted for use at the recommended Volume per Test. We typically use 1 × 10^6 cells in a 100-µl experimental sample (a test).
  2. An isotype control should be used at the same concentration as the antibody of interest.
  3. Source of all serum proteins is from USDA inspected abattoirs located in the United States.
  4. Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
  5. The Alexa Fluor®, Pacific Blue™, and Cascade Blue® dye antibody conjugates in this product are sold under license from Molecular Probes, Inc. for research use only, excluding use in combination with microarrays, or as analyte specific reagents. The Alexa Fluor® dyes (except for Alexa Fluor® 430), Pacific Blue™ dye, and Cascade Blue® dye are covered by pending and issued patents.
  6. Alexa Fluor® 647 fluorochrome emission is collected at the same instrument settings as for allophycocyanin (APC).
  7. Alexa Fluor® is a registered trademark of Molecular Probes, Inc., Eugene, OR.
  8. For fluorochrome spectra and suitable instrument settings, please refer to our Multicolor Flow Cytometry web page at www.bdbiosciences.com/colors.
  9. Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.
Show More blue down arrow Show Less blue up arrow
560793 Rev. 3
Antibody Details
Down Arrow Up Arrow
TRA-1-81

The TRA-1-81 monoclonal antibody reacts with a pluripotent stem cell-specific epitope on a high molecular weight transmembrane glycoprotein.  The TRA-1-81 antigen is an epitope on the same keratan sulfate core molecule, podocalyxin, as 4 other distinct antigens on tumor-derived cell lines, TRA-1-60, GCTM2, K4, and K21.  The expression of TRA-1-81 antigen is stage-specific and can be used to characterize embryonic cells and monitor their differentiation.  The antigen is found on teratocarcinoma (embryonal carcinoma or EC), embryonic inner cell mass (but not morula or trophoblast), and embryonic stem (ES) cells.  As human EC and ES cells undergo differentiation, expression of TRA-1-81 antigen is lost.

  

560793 Rev. 3
Format Details
Down Arrow Up Arrow
Alexa Fluor™ 647
Alexa Fluor™ 647 Dye is part of the BD red family of dyes. This is a small organic fluorochrome with an excitation maximum (Ex Max) at 653-nm and an emission maximum (Em Max) at 669-nm. Alexa Fluor™ 647 is designed to be excited by the Red laser (627-640 nm) and detected using an optical filter centered near 670-nm (e.g., a 660/20 nm bandpass filter). Please ensure that your instrument’s configurations (lasers and optical filters) are appropriate for this dye.
altImg
Alexa Fluor™ 647
653 nm
669 nm
560793 Rev.3
Citations & References
Down Arrow Up Arrow
View product citations for antibody "560793" on CiteAb

Development References (7)

  1. Andrews PW, Banting G, Damanov I, Arnaud D, Avner P. Three monoclonal antibodies defining distinct differentiation antigens associated with different high molecular weight polypeptides on the surface of human embryonal carcinoma cells. Hybridoma. 1984; 3(4):347-361. (Immunogen). View Reference
  2. Badcock G, Pigott C, Goepel J, Andrews PW. The human embryonal carcinoma marker antigen TRA-1-60 is a sialylated keratan sulfate proteoglycan. Cancer Res. 1999; 59:4715-4719. (Clone-specific: Immunoprecipitation, Western blot). View Reference
  3. Draper JS, Pigott C, Thomson JA, Andrews PW. Surface antigens of human embryonic stem cells: changes upon differentiation in culture. J Anat. 2002; 200:249-258. (Clone-specific: Flow cytometry). View Reference
  4. Henderson JK, Draper JS, Baillie HS, et al. Preimplantation human embryos and embryonic stem cells show comparable expression of stage-specific embryonic antigens. Stem Cells. 2002; 20:329-337. (Clone-specific: Flow cytometry, Immunofluorescence). View Reference
  5. Schopperle WM, DeWolf WC. The TRA-1-60 and TRA-1-81 human pluripotent stem cell markers are expressed on podocalyxin in embryonal carcinoma. Stem Cells. 2007; 25:723-730. (Clone-specific: Immunofluorescence, Western blot). View Reference
  6. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998; 282:1145-1147. (Clone-specific: Immunocytochemistry (cytospins)). View Reference
  7. Thomson JA, Kalishman J, Golos TG, et al. Isolation of a primate embryonic stem cell line. Proc Natl Acad Sci U S A. 1995; 92:7844-7848. (Clone-specific: Immunocytochemistry (cytospins)). View Reference
View All (7) View Less
560793 Rev. 3

Please refer to Support Documents for Quality Certificates

 

Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described

 

Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims.  Comparisons are not made against non-BD technologies, unless otherwise noted.

For Research Use Only. Not for use in diagnostic or therapeutic procedures.